PetMed Express, Inc. (PETS)
USD 5.28
(-5.38%)
USD 5.28
(-5.38%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -7.46 Million USD | -3303.43% |
| 2023 | 233 Thousand USD | -98.76% |
| 2022 | 18.71 Million USD | -21.75% |
| 2021 | 23.91 Million USD | -7.47% |
| 2020 | 25.85 Million USD | -31.5% |
| 2019 | 37.74 Million USD | 1.23% |
| 2018 | 37.28 Million USD | 56.53% |
| 2017 | 23.81 Million USD | 15.81% |
| 2016 | 20.56 Million USD | 17.84% |
| 2015 | 17.45 Million USD | -2.89% |
| 2014 | 17.97 Million USD | 4.7% |
| 2013 | 17.16 Million USD | 3.04% |
| 2012 | 16.65 Million USD | -20.18% |
| 2011 | 20.87 Million USD | -19.73% |
| 2010 | 26 Million USD | 13.17% |
| 2009 | 22.97 Million USD | 14.75% |
| 2008 | 20.02 Million USD | 38.62% |
| 2007 | 14.44 Million USD | 19.73% |
| 2006 | 12.06 Million USD | 50.6% |
| 2005 | 8.01 Million USD | 37.79% |
| 2004 | 5.81 Million USD | 78.46% |
| 2003 | 3.25 Million USD | 294.66% |
| 2002 | 825.41 Thousand USD | 129.2% |
| 2001 | -2.82 Million USD | -57.54% |
| 2000 | -1.79 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -5.01 Million USD | -147.46% |
| 2024 Q3 | -2.02 Million USD | -2795.71% |
| 2024 Q1 | -887 Thousand USD | 82.61% |
| 2024 Q2 | -70 Thousand USD | 92.11% |
| 2024 FY | -7.46 Million USD | -3303.43% |
| 2023 Q1 | 2.77 Million USD | -54.25% |
| 2023 FY | 233 Thousand USD | -98.76% |
| 2023 Q2 | 2.57 Million USD | -7.06% |
| 2023 Q3 | -19 Thousand USD | -100.74% |
| 2023 Q4 | -5.1 Million USD | -26752.63% |
| 2022 Q1 | 4.42 Million USD | -35.0% |
| 2022 FY | 18.71 Million USD | -21.75% |
| 2022 Q2 | 6.34 Million USD | 43.38% |
| 2022 Q4 | 6.06 Million USD | 42.49% |
| 2022 Q3 | 4.25 Million USD | -32.95% |
| 2021 Q2 | 8.41 Million USD | 8.29% |
| 2021 FY | 23.91 Million USD | -7.47% |
| 2021 Q3 | 7.61 Million USD | -9.52% |
| 2021 Q4 | 6.81 Million USD | -10.5% |
| 2021 Q1 | 7.76 Million USD | 10.92% |
| 2020 Q4 | 7 Million USD | 2.38% |
| 2020 Q3 | 6.84 Million USD | 2.63% |
| 2020 Q1 | 5.34 Million USD | -19.28% |
| 2020 Q2 | 6.66 Million USD | 24.74% |
| 2020 FY | 25.85 Million USD | -31.5% |
| 2019 Q2 | 10.75 Million USD | -14.54% |
| 2019 Q1 | 12.58 Million USD | 23.56% |
| 2019 FY | 37.74 Million USD | 1.23% |
| 2019 Q4 | 6.61 Million USD | -15.0% |
| 2019 Q3 | 7.78 Million USD | -27.58% |
| 2018 Q2 | 8.76 Million USD | -5.56% |
| 2018 Q1 | 9.27 Million USD | 23.63% |
| 2018 Q4 | 10.18 Million USD | 12.35% |
| 2018 FY | 37.28 Million USD | 56.53% |
| 2018 Q3 | 9.06 Million USD | 3.47% |
| 2017 Q4 | 7.5 Million USD | 55.57% |
| 2017 Q2 | 4.89 Million USD | -25.71% |
| 2017 Q1 | 6.59 Million USD | 21.71% |
| 2017 FY | 23.81 Million USD | 15.81% |
| 2017 Q3 | 4.82 Million USD | -1.55% |
| 2016 Q4 | 5.41 Million USD | 10.8% |
| 2016 FY | 20.56 Million USD | 17.84% |
| 2016 Q3 | 4.89 Million USD | 8.62% |
| 2016 Q2 | 4.5 Million USD | -21.8% |
| 2016 Q1 | 5.75 Million USD | 16.28% |
| 2015 Q1 | 4.97 Million USD | 9.88% |
| 2015 Q2 | 2.73 Million USD | -45.06% |
| 2015 Q3 | 4.79 Million USD | 75.59% |
| 2015 Q4 | 4.95 Million USD | 3.21% |
| 2015 FY | 17.45 Million USD | -2.89% |
| 2014 FY | 17.97 Million USD | 4.7% |
| 2014 Q2 | 4.15 Million USD | -12.72% |
| 2014 Q3 | 4.54 Million USD | 9.42% |
| 2014 Q4 | 4.52 Million USD | -0.33% |
| 2014 Q1 | 4.75 Million USD | 3.32% |
| 2013 FY | 17.16 Million USD | 3.04% |
| 2013 Q4 | 4.6 Million USD | 0.55% |
| 2013 Q3 | 4.57 Million USD | 13.46% |
| 2013 Q2 | 4.03 Million USD | 2.07% |
| 2013 Q1 | 3.95 Million USD | -1.05% |
| 2012 Q4 | 3.99 Million USD | 2.46% |
| 2012 Q2 | 3.93 Million USD | -18.75% |
| 2012 FY | 16.65 Million USD | -20.18% |
| 2012 Q3 | 3.89 Million USD | -0.81% |
| 2012 Q1 | 4.83 Million USD | 16.67% |
| 2011 Q4 | 4.14 Million USD | -8.31% |
| 2011 FY | 20.87 Million USD | -19.73% |
| 2011 Q3 | 4.52 Million USD | -9.14% |
| 2011 Q1 | 7.22 Million USD | 18.99% |
| 2011 Q2 | 4.97 Million USD | -31.11% |
| 2010 Q1 | 8.07 Million USD | 42.94% |
| 2010 Q2 | 6.26 Million USD | -22.41% |
| 2010 FY | 26 Million USD | 13.17% |
| 2010 Q3 | 5.59 Million USD | -10.77% |
| 2010 Q4 | 6.07 Million USD | 8.62% |
| 2009 Q1 | 6.62 Million USD | 35.03% |
| 2009 Q2 | 5.82 Million USD | -12.08% |
| 2009 Q4 | 5.64 Million USD | 15.67% |
| 2009 FY | 22.97 Million USD | 14.75% |
| 2009 Q3 | 4.88 Million USD | -16.1% |
| 2008 Q4 | 4.9 Million USD | 11.19% |
| 2008 FY | 20.02 Million USD | 38.62% |
| 2008 Q3 | 4.4 Million USD | -2.56% |
| 2008 Q2 | 4.52 Million USD | -26.8% |
| 2008 Q1 | 6.18 Million USD | 70.61% |
| 2007 FY | 14.44 Million USD | 19.73% |
| 2007 Q4 | 3.62 Million USD | 31.58% |
| 2007 Q3 | 2.75 Million USD | -16.92% |
| 2007 Q2 | 3.31 Million USD | -30.21% |
| 2007 Q1 | 4.75 Million USD | 51.33% |
| 2006 Q4 | 3.13 Million USD | 17.47% |
| 2006 Q3 | 2.67 Million USD | -1.43% |
| 2006 Q2 | 2.71 Million USD | -23.46% |
| 2006 Q1 | 3.54 Million USD | 46.14% |
| 2006 FY | 12.06 Million USD | 50.6% |
| 2005 Q2 | 1.81 Million USD | -0.36% |
| 2005 Q1 | 1.81 Million USD | 35.79% |
| 2005 Q3 | 1.95 Million USD | 8.03% |
| 2005 Q4 | 2.42 Million USD | 23.83% |
| 2005 FY | 8.01 Million USD | 37.79% |
| 2004 Q2 | 1.81 Million USD | 26.92% |
| 2004 FY | 5.81 Million USD | 78.46% |
| 2004 Q3 | 1.22 Million USD | -32.68% |
| 2004 Q1 | 1.43 Million USD | -16.5% |
| 2004 Q4 | 1.33 Million USD | 9.39% |
| 2003 FY | 3.25 Million USD | 294.66% |
| 2003 Q1 | 902.32 Thousand USD | -22.84% |
| 2003 Q4 | 1.71 Million USD | 294.66% |
| 2003 Q2 | 204.88 Thousand USD | -77.29% |
| 2003 Q3 | 434.71 Thousand USD | 112.17% |
| 2002 Q1 | -1.09 Million USD | 3.13% |
| 2002 Q4 | 1.16 Million USD | 230.94% |
| 2002 Q3 | 353.34 Thousand USD | -10.18% |
| 2002 Q2 | 393.37 Thousand USD | 136.07% |
| 2002 FY | 825.41 Thousand USD | 129.2% |
| 2001 Q2 | -298.6 Thousand USD | 71.23% |
| 2001 FY | -2.82 Million USD | -57.54% |
| 2001 Q1 | -1.03 Million USD | 18.91% |
| 2001 Q3 | -364.2 Thousand USD | -21.97% |
| 2001 Q4 | -1.12 Million USD | -209.16% |
| 2000 FY | -1.79 Million USD | 0.0% |
| 2000 Q4 | -1.28 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -19.93 Million USD | 62.559% |
| BIMI International Medical Inc. | -22.35 Million USD | 66.608% |
| China Jo-Jo Drugstores, Inc. | -4.23 Million USD | -76.278% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | -24.41 Million USD | 69.424% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | -24.41 Million USD | 69.424% |
| Leafly Holdings, Inc. | -9.49 Million USD | 21.415% |
| Leafly Holdings, Inc. | -9.49 Million USD | 21.415% |
| LifeMD, Inc. | -20.59 Million USD | 63.76% |
| LifeMD, Inc. | -20.59 Million USD | 63.76% |
| TRxADE HEALTH, Inc. | -17.84 Million USD | 58.17% |
| Walgreens Boots Alliance, Inc. | -8.63 Billion USD | 99.914% |